Product category:
Microbiology
News Release from: Oxoid | Subject: Oxoid VDRL and TPHA tests
Edited by the Laboratorytalk Editorial
Team on 28 September 2006
Convenient tests for the confirmation of
syphilis
Amid the increasing incidence of syphilis in the UK, Oxoid offers clinical laboratories convenient tools for the reliable diagnosis of syphilis infection
According to the Health Protection Agency, the number of sexually transmitted infections in the UK has continued to increase, rising by 3% from 2004 to 2005 The biggest increase was seen in the number of new cases of syphilis, which rose by 23% to 2807 cases in 2005
This article was originally published on Laboratorytalk on 18 Jan 2002 at 8.00am (UK)
Related stories
Test to detect C difficile toxin A
Clostridium difficile is thought to be present in up to a fifth of hospital patients, and can cause the life-threatening condition PMC. Oxoid reports continuing sales growth for its diagnostic test
Faced with these difficulties, laboratories require accurate and reliable methods that are easily accessible and cost effective.
Oxoid provides such tests for use in the diagnosis of syphilis infection.
The Oxoid VDRL carbon antigen test (DR525M) is a rapid agglutination test that detects reagin antibodies (found in active disease) in serum or plasma in just 8 minutes.
The Oxoid TPHA Test (DR0530M) is a sensitive passive haemagglutination test, that detects specific Treponema pallidum antibodies in serum within one hour.
Used in combination, the Oxoid VDRL and TPHA tests provide accurate and reliable confirmation of active syphilis infection.
No specialised equipment is required and results are clearly visible and easily interpreted. Request a free brochure from Oxoid ...
• Oxoid: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page


